Recent Posts
See AllOn August 3rd, a new treatment developed by the TB Alliance has been approved by the European Commission for some of the most drug-resistant forms of TB. Learn more about the new Pretomanid drug here.
Mounting evidence suggests the ongoing pandemic will have significant implications for the treatment and pathology of other burdensome diseases—tuberculosis included. Read about it here.